drugset / Trial / NCT03788889
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this study will aim to determine if adding phenobarbital or ketamine to a symptom-triggered benzodiazepine regimen decreases the rate of intensive care unit admissions during the treatment of alcohol withdrawal syndrome when compared to symptom-triggered benzodiazepine therapy alone.
Timeline
- Start
- 2019-04-12
- Primary completion
- 2019-04-12
- Completion
- 2019-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | 0.4 mg/kg | — |
| Comparator | Phenobarbital | Unknown | 130 mg | Intravenous |
| Comparator | Lorazepam | Small molecule | — | — |